The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis

Mahdavi Gorabi, Armita and Kiaie, Nasim and Reiner, Željko and Carbone, Federico and Montecucco, Fabrizio and Sahebkar, Amirhossein (2019) The therapeutic potential of nanoparticles to reduce inflammation in atherosclerosis. Biomolecules, 9 (9). ISSN 2218-273X

PDF - Published Version Download (647kB)

Abstract

Chronic inflammation is one of the main determinants of atherogenesis. The traditional medications for treatment of atherosclerosis are not very efficient in targeting atherosclerotic inflammation. Most of these drugs are non-selective, anti-inflammatory and immunosuppressive agents that have adverse effects and very limited anti-atherosclerotic effects, which limits their systemic administration. New approaches using nanoparticles have been investigated to specifically deliver therapeutic agents directly on atherosclerotic lesions. The use of drug delivery systems, such as polymeric nanoparticles, liposomes, and carbon nanotubes are attractive strategies, but some limitations exist. For instance, nanoparticles may alter the drug kinetics, based on the pathophysiological mechanisms of the diseases. In this review, we will update pathophysiological evidence for the use of nanoparticles to reduce inflammation and potentially prevent atherogenesis in different experimental models.

Actions (login required)

View Item

Downloads